A US Food and Drug Administration (FDA) advisory panel has rejected the atypical antipsychotic pimavanserin (Nuplazid, Acadia Pharmaceuticals) for the
Tag - News Alert
The US Food and Drug Administration (FDA) has approved a supplemental indication for setmelanotide (Imcivree, Rhythm Pharmaceuticals) injection for chronic
Immunotherapy with nivolumab (Opdivo) is now approved in the United States for first-line use in the treatment of unresectable advanced or metastatic
In a final decision on the funding of the controversial Alzheimer’s drug aducanumab (Aduhelm), federal officials largely stuck to their draft plan to
The US Food and Drug Administration (FDA) has approved nivolumab for neoadjuvant treatment of non-small cell lung cancer (NSCLC) in combination with platinum
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the calcitonin gene-related
The US Food and Drug Administration (FDA) has approved the dual orexin receptor antagonist daridorexant (Quviviq) for the treatment of insomnia in adults, the
The US Food and Drug Administration (FDA) has expanded approval of lumateperone (Caplyta) to include treatment of adults with depressive episodes associated
Hospital and physician groups on Thursday announced their plan to sue the federal government over its plan for addressing disputes about surprise medical
The Food and Drug Administration on November 12 approved ropeginterferon alfa-2b-njft (Besremi), a monopegylated, long-acting interferon, for adults with
